文献速递妇科

子宫内膜癌前哨淋巴结定位与淋巴结清扫术的系统综述与荟萃分析

Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis.
PubMed 文献 · Gynecol Oncol · 2019-04-02

该系统综述与荟萃分析纳入6项比较研究、共3536例子宫内膜癌患者,比较前哨淋巴结定位与淋巴结清扫术的 staging 效果。汇总数据显示前哨淋巴结定位组盆腔阳性淋巴结检出率高于淋巴结清扫术组,而腹主动脉旁阳性淋巴结检出率及复发率(总体复发与淋巴结复发)两组无显著差异。作者结论为前哨淋巴结定位在腹主动脉旁淋巴结受累检出及复发率方面不劣于标准淋巴结清扫术,在盆腔阳性淋巴结检出能力上可考虑优于淋巴结清扫术,需进一步随机研究评估长期有效性。

要点

  • 前哨淋巴结定位组盆腔阳性淋巴结检出184/1249(14.7%),淋巴结清扫术组228/2287(9.9%),OR 2.03(95%CI 1.30至3.18),p=0.002。
  • 总体复发率前哨淋巴结定位组4.3%、淋巴结清扫术组7.3%,OR 0.90(95%CI 0.58至1.38),p=0.63,无显著差异。

核心结论

  • 荟萃分析表明前哨淋巴结定位在腹主动脉旁淋巴结受累检出及复发率(任何部位复发和淋巴结复发)方面不劣于标准淋巴结清扫术。
  • 在盆腔阳性淋巴结检出能力上,前哨淋巴结定位可考虑优于淋巴结清扫术。
  • 需进一步随机研究评估前哨淋巴结定位的长期有效性。

研究设计与样本

  • 系统综述与荟萃分析,已在国际前瞻性系统综述注册平台注册。
  • 纳入6项比较研究,共3536例患者;其中1249例(35.3%)接受前哨淋巴结定位,2287例(64.7%)接受淋巴结清扫术。

主要发现

  • 盆腔阳性淋巴结检出:前哨淋巴结定位组184/1249(14.7%) vs 淋巴结清扫术组228/2287(9.9%),OR 2.03(95%CI 1.30至3.18),p=0.002。
  • 总体复发率:前哨淋巴结定位组4.3% vs 淋巴结清扫术组7.3%,OR 0.90(95%CI 0.58至1.38),p=0.63。
  • 淋巴结复发率两组统计学相似:前哨淋巴结定位组1.2% vs 淋巴结清扫术组1.7%,OR 1.51(95%CI 0.70至3.29),p=0.29。

关键数值与推荐

  • 盆腔阳性淋巴结检出OR 2.03(95%CI 1.30至3.18),p=0.002,前哨淋巴结定位组高于淋巴结清扫术组。
  • 总体复发OR 0.90(95%CI 0.58至1.38),p=0.63,两组无显著差异。
  • 淋巴结复发OR 1.51(95%CI 0.70至3.29),p=0.29,两组统计学相似。

临床怎么用

  • 原文结论指出前哨淋巴结定位在腹主动脉旁淋巴结受累检出及复发率方面不劣于标准淋巴结清扫术,在盆腔阳性淋巴结检出能力上可考虑优于淋巴结清扫术。

局限性

  • 原文指出支持以前哨淋巴结定位替代常规淋巴结清扫术的证据仍然有限。
  • 原文结论提出需进一步随机研究评估前哨淋巴结定位的长期有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sentinel node mapping is increasingly being utilized for endometrial cancer staging. However, only limited evidence supporting the adoption of sentinel node mapping instead of conventional lymphadenectomy is still available. Here, we aimed to review the current evidence comparing sentinel node mapping and lymphadenectomy in endometrial cancer staging. This systematic review was registered in the International Prospective Register of Systematic Reviews. Six comparative studies were included. Overall, 3536 patients were included: 1249 (35.3%) and 2287 (64.7%), undergoing sentinel node mapping and lymphadenectomy, respectively. Pooled data suggested that positive pelvic nodes were detected in 184 out of 1249 (14.7%) patients having sentinel node mapping and 228 out of 2287 (9.9%) patients having lymphadenectomy (OR: 2.03; (95%CI: 1.30 to 3.18); p = 0.002). No difference in detection of positive nodes located in the paraaortic was observed (OR: 93 (95%CI: 0.39 to 2.18); p = 0.86). Overall recurrence rate was 4.3% and 7.3% after sentinel node mapping and lymphadenectomy, respectively (OR: 0.90 (95%CI: 0.58 to 1.38); p = 0.63). Similarly, nodal recurrences were statistically similar between groups (1.2% vs. 1.7%; OR: 1.51 (95%CI: 0.70 to 3.29); p = 0.29). In conclusion, our meta-analysis underlines that sentinel node mapping is non-inferior to standard lymphadenectomy in term of detection of paraaortic nodal involvement and recurrence rates (any site and nodal recurrence); while, focusing on the ability to detect positive pelvic nodes, sentinel node mapping could be consider superior to lymphadenectomy. Further randomized studies are needed to asses long term effectiveness of sentinel node mapping.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bogani G, Murgia F, Ditto A, et al. Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol. 2019. PMID: 30952370. doi:10.1016/j.ygyno.2019.03.254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。